Literature DB >> 33420145

Effects of pre-extraction intermittent PTH administration on extraction socket healing in bisphosphonate administered ovariectomized rats.

Jae-Young Kim1, Hyo-Won Jang2, Jung-In Kim3, In-Ho Cha4.   

Abstract

The purpose of this study was to investigate the effect of administering intermittent parathyroid hormone (iPTH) before tooth extraction versus after tooth extraction on the risk of developing MRONJ in experimental animal model. Twenty-five ovariectomized rats received 6 weeks of bisphosphonate therapy. They were classified into 3 groups, based on the timing of the medication, as Control, Pre-PTH and Post-PTH groups. For Control group, normal saline was administered before and after tooth extraction. iPTH was administered during 4 weeks before tooth extraction for Pre-PTH group and after tooth extraction for Post-PTH group. The animals were euthanized 8 weeks after tooth extraction. Macroscopic, histological, micro-computed tomography (micro-CT), and histomorphometric examinations were conducted. The incidences of impaired healing were 11.11% both in Pre-PTH and Post-PTH groups, which was lower than the Control group (42.86%). Bone healing in the extraction socket, based on micro-CT and histomorphometry evaluations, was best in Post-PTH and worst in Control group. The Pre-PTH group showed moderate healing pattern. Despite of limitations in this study, the authors identified Pre-PTH group seems to have positive effect on extraction socket healing. With regard to timing, administering iPTH after tooth extraction was superior to applying it before tooth extraction.

Entities:  

Year:  2021        PMID: 33420145      PMCID: PMC7794385          DOI: 10.1038/s41598-020-79787-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  29 in total

1.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy.

Authors:  Arthur N Lau; Jonathan D Adachi
Journal:  J Rheumatol       Date:  2009-08       Impact factor: 4.666

3.  Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.

Authors:  Mohammad Zandi; Arash Dehghan; Khaled Ghadermazi; Hamid Malekzadeh; Mahdi Akbarzadeh
Journal:  J Craniomaxillofac Surg       Date:  2015-08-20       Impact factor: 2.078

4.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

5.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

6.  Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays.

Authors:  Douglas D Damm; David M Jones
Journal:  Gen Dent       Date:  2013-08

7.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

8.  The Change of Bone Metabolism in Ovariectomized Rats : Analyses of MicroCT Scan and Biochemical Markers of Bone Turnover.

Authors:  Kyung-Hyuk Yoon; Dae-Chul Cho; Song-Hee Yu; Kyoung-Tae Kim; Younghoon Jeon; Joo-Kyung Sung
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30

9.  A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens.

Authors:  I S Scott; T M Heath; L S Morris; S M Rushbrook; K Bird; S L Vowler; M J Arends; N Coleman
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

10.  Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing.

Authors:  S Kuroshima; P Entezami; L K McCauley; J Yamashita
Journal:  Osteoporos Int       Date:  2013-12-04       Impact factor: 4.507

View more
  3 in total

1.  Selenium-modified calcium phosphate cement can accelerate bone regeneration of osteoporotic bone defect.

Authors:  Tian-Lin Li; Zhou-Shan Tao; Xing-Jing Wu; Min Yang; Hong-Guang Xu
Journal:  J Bone Miner Metab       Date:  2021-06-29       Impact factor: 2.626

Review 2.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

Review 3.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.